GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: MRS-2541 is in preclinical development as a novel antibacterial treatment for nosocomial infections caused by drug-resistant Gram-positive pathogens. Functionally, it blocks bacterial protein synthesis by inhibiting type 1 methionyl-tRNA synthetase in Gram-positive bacteria [3]. MRS-2541 is one of the chemical structures claimed in patent WO2024242729A1 filed by the University of Washington [2].
|
|
|||||||||||||||||||||||||||||||||||
Download 2D Structure ![]() |
|
| Canonical SMILES | Download |
| Isomeric SMILES | Download |
| InChI standard identifier | Download |
| InChI standard key | Download |
Molecular structure representations generated using Open Babel